As of September 2026, 133 paid clinical trials are recruiting for Solid tumor in New York, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in New York, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Cancer Center | Breast Cancer, Prostate Cancer, Endometrial Cancer | 466 |
| NYU Langone Health | Prostate Cancer, Lung Cancer, Cardiovascular Diseases | 323 |
| Icahn School of Medicine at Mount Sinai | Crohn's Disease, Myelofibrosis, Prostate Cancer | 250 |
| Columbia University Irving Medical Center | Insulin Resistance, Obesity, Alzheimer Disease | 168 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | Breast Cancer, Multiple Myeloma, Lung Cancer | 156 |
| Weill Cornell Medicine | Depression, Heart Failure, Prostate Cancer | 139 |
| Columbia University Medical Center | Breast Cancer, Advanced Solid Tumor, Chronic Lymphocytic Leukemia | 118 |
| Mount Sinai Hospital | Heart Failure, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 117 |
| Columbia University | Amyotrophic Lateral Sclerosis, Obstetrical Complications, Type 1 Diabetes Mellitus | 112 |
| Hospital for Special Surgery | Systemic Lupus Erythematosus, Rheumatoid Arthritis, Anterior Cruciate Ligament Injuries | 63 |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 52 |
| NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Neuroblastoma | 47 |
| Mount Sinai West | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Intracerebral Hemorrhage | 45 |
| Lenox Hill Hospital | Anatomic Stage II Breast Cancer AJCC v8, Atrial Fibrillation, Head and Neck Squamous Cell Carcinoma | 44 |
| Mount Sinai | Ovarian Cancer, AML, Advanced Solid Tumors | 43 |
| Weill Cornell Medical College | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 41 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | Breast Cancer, Pancreatic Cancer, Prostate Cancer | 41 |
| NYP/Weill Cornell Medical Center | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Muscle Invasive Bladder Urothelial Carcinoma | 31 |
| New York University | Inflammatory Bowel Disease (IBD), Acute or Chronic Coronary Artery Disease, Adenine Phosphoribosyltransferase Deficiency | 28 |
| Memorial Sloan-Kettering Cancer Center | Advanced Solid Tumor, Autoimmune Diseases, Breast Cancer | 23 |
| NYU Langone | Solid Tumor, Adult, Acute Gastrointestinal Bleeding, Advanced Breast Cancer | 22 |
| Manhattan Eye Ear and Throat Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 21 |
| Mount Sinai Chelsea | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma | 21 |
| The Mount Sinai Hospital | Homocystinuria, Intracerebral Hemorrhage, Ischemic Stroke | 21 |
| Montefiore Medical Center | Mitral Regurgitation, Coronary Artery Disease, AML, Adult | 20 |
Recruiting trials in New York grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 3,395 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in New York include Breast Cancer (91), Prostate Cancer (75), Ovarian Cancer (43), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in New York are Cancer & tumors (1,129), Cardiovascular (203), Neurology & pain (202). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.